The source of plasma dihydrotestosterone (DHT) (17β-hydroxy-5α-androstan-3-one) in humans has been investigated by infusing two potential peripheral precursors, testosterone (T) and androstenedione (A). Metabolic clearance rates (MCR), conversion ratios (CR), transfer constants (ρ), and blood production rates (PB) were calculated. Plasma testosterone and dihydrotestosterone were measured by competitive binding techniques. The MCRDHT was 652 ±35 (SD) liters/day in five males and 314 ±63 (SD) liters/day in four adult females. In each individual, the MCRDHT was significantly lower than MCRT as predicted by testosterone-binding protein affinity studies. The PBDHT was 302 ±65 (SD) μg/day in males and 56 ±26 μg/day in females. Testosterone and androstenedione are precursors (prehormones) for plasma dihydrotestosterone. The conversion ratio CRBBT-DHT, calculated as the ratio of counts per minute per liter of plasma of product to precursor after infusion of labeled precursor, was 5.6 ±0.6 (SD)% (six subjects) in the male and 3.5 ±0.4 (SD)% (four subjects) in the female. CRBBA-DHT after androstenedione infusion to three female subjects averaged 9.2%. No dihydrotestosterone back conversion was detected (< 0.2%). The transfer constants were [ρ]BBT-DHT, 3.9 ±1.0% (male) and 1.7 ±0.6% (female), and [ρ]BBA-DHT average was 13.3% in three female subjects. Using either plasma testosterone and dihydrotestosterone values from our subjects and mean androstenedione values as reported in the literature, approximate contributions can be calculated. Testosterone conversion accounts for at least 70% of plasma DHT in the male, but less than 20% in the normal female. Androstenedione appears to be a major prehormone of plasma dihydrotestosterone accounting for at least two-thirds plasma dihydrotestosterone by peripheral conversion in adult females. In three normal women undergoing tubal ligation, there was an unimpressive gradient between ovarian vein and peripheral plasma dihydrotestosterone. It is suggested that dihydrotestosterone in the blood does not arise from direct secretion but may reflect events occurring in peripheral androgen target tissues.
T. Ito, R. Horton
Usage data is cumulative from January 2022 through January 2023.
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.